Literature DB >> 17081665

Use of methylene blue as a diagnostic aid in early detection of oral cancer and precancerous lesions.

Ya-Wei Chen1, Jiun-Sheng Lin, Jenny Hwai-Jen Fong, I-Kai Wang, Shen-Ju Chou, Chen-Hsian Wu, Man-Tin Lui, Che-Shoa Chang, Shou-Yen Kao.   

Abstract

We assessed the sensitivity, specificity, and positive and negative predictive value of methylene blue staining in the diagnosis of oral cancer in 58 patients. The sensitivity was 90%, the specificity 69%, positive predictive value 74%, and negative predictive value 87%. Because of the number of false negatives and false positives we recommend that the diagnosis should always be confirmed by histopathological examination of a biopsy specimen. Methylene blue staining may, however, be useful as a screening tool for oral cancer in large, high-risk groups in a similar way to the more expensive toluidine blue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081665     DOI: 10.1016/j.bjoms.2006.08.017

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  12 in total

Review 1.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Authors:  Richard Macey; Tanya Walsh; Paul Brocklehurst; Alexander R Kerr; Joseph L Y Liu; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya; Crispian Scully
Journal:  Cochrane Database Syst Rev       Date:  2015-05-29

Review 2.  Precancerous lesions of oral mucosa.

Authors:  Gurkan Yardimci; Zekayi Kutlubay; Burhan Engin; Yalcin Tuzun
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

Review 3.  Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.

Authors:  Tanya Walsh; Saman Warnakulasuriya; Mark W Lingen; Alexander R Kerr; Graham R Ogden; Anne-Marie Glenny; Richard Macey
Journal:  Cochrane Database Syst Rev       Date:  2021-12-10

Review 4.  Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.

Authors:  Shao-Hua Yang; Wenjun Li; Nathalie Sumien; Michael Forster; James W Simpkins; Ran Liu
Journal:  Prog Neurobiol       Date:  2015-11-18       Impact factor: 11.685

Review 5.  Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.

Authors:  Tanya Walsh; Joseph L Y Liu; Paul Brocklehurst; Anne-Marie Glenny; Mark Lingen; Alexander R Kerr; Graham Ogden; Saman Warnakulasuriya; Crispian Scully
Journal:  Cochrane Database Syst Rev       Date:  2013-11-21

Review 6.  Cancer Screening: Should Cancer Screening be Essential Component of Primary Health Care in Developing Countries?

Authors:  Saurabh Bobdey; Ganesh Balasubramanium; Abhinendra Kumar; Aanchal Jain
Journal:  Int J Prev Med       Date:  2015-07-06

Review 7.  Non-invasive visual tools for diagnosis of oral cancer and dysplasia: A systematic review.

Authors:  I Giovannacci; P Vescovi; M Manfredi; M Meleti
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-05-01

8.  Methylene Blue as a Diagnostic Aid in the Early Detection of Potentially Malignant and Malignant Lesions of Oral Mucosa.

Authors:  Abraham Lejoy; Rai Arpita; Burde Krishna; Naikmasur Venkatesh
Journal:  Ethiop J Health Sci       Date:  2016-05

9.  Methylene blue as an early diagnostic marker for oral precancer and cancer.

Authors:  Akhtar Riaz; Balasundari Shreedhar; Mala Kamboj; S Natarajan
Journal:  Springerplus       Date:  2013-03-09

10.  Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.

Authors:  Tanya Walsh; Richard Macey; Alexander R Kerr; Mark W Lingen; Graham R Ogden; Saman Warnakulasuriya
Journal:  Cochrane Database Syst Rev       Date:  2021-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.